David Abrams - Abrams Capital Management,
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 1.95 | SEC | ||
| 2023 Q4 | 5,996,836 | 1.95 | Reduce 24.72% | 0.66 | $10.44 | $62,606,968 | SEC |
| 2023 Q3 | 7,966,433 | 2.68 | $10.20 | $81,257,617 | SEC | ||
| 2023 Q2 | 7,966,433 | 1.72 | $7.53 | $59,987,240 | SEC | ||
| 2023 Q1 | 7,966,433 | 2.23 | Reduce 50.00% | 2.59 | $8.85 | $70,502,932 | SEC |
| 2022 Q4 | 15,932,865 | 5.18 | Reduce 33.33% | 1.85 | $9.12 | $145,307,729 | SEC |
| 2022 Q3 | 23,899,296 | 5.56 | Reduce 0.61% | 0.03 | $8.07 | $192,867,000 | SEC |
| 2022 Q2 | 24,046,356 | 4.86 | $7.52 | $180,829,000 | SEC | ||
| 2022 Q1 | 24,046,356 | 5.27 | $9.39 | $225,795,000 | SEC | ||
| 2021 Q4 | 24,046,356 | 4.23 | $8.01 | $192,611,000 | SEC | ||
| 2021 Q3 | 24,046,356 | 5.11 | $9.74 | $234,212,000 | SEC | ||
| 2021 Q2 | 24,046,356 | 5.29 | $9.90 | $238,059,000 | SEC | ||
| 2021 Q1 | 24,046,356 | 6.25 | $11.54 | $277,495,000 | SEC | ||
| 2020 Q4 | 24,046,356 | 6.54 | $9.65 | $232,047,000 | SEC | ||
| 2020 Q3 | 24,046,356 | 6.85 | $9.01 | $216,658,000 | SEC | ||
| 2020 Q2 | 24,046,356 | 9.58 | $12.33 | $296,492,000 | SEC | ||
| 2020 Q1 | 24,046,356 | 8.50 | $8.98 | $215,936,000 | SEC | ||
| 2019 Q4 | 24,046,356 | 7.32 | $9.80 | $235,654,000 | SEC | ||
| 2019 Q3 | 24,046,356 | 4.63 | Add 33.25% | 1.16 | $6.88 | $165,439,000 | SEC |
| 2019 Q2 | 18,046,356 | 4.52 | $9.23 | $166,568,000 | SEC | ||
| 2019 Q1 | 18,046,356 | 7.95 | Reduce 2.57% | 0.30 | $15.68 | $282,967,000 | SEC |
| 2018 Q4 | 18,522,372 | 11.80 | Reduce 5.12% | 0.57 | $15.42 | $285,615,000 | SEC |
| 2018 Q3 | 19,522,372 | 11.12 | Reduce 1.12% | 0.15 | $21.54 | $420,512,000 | SEC |
| 2018 Q2 | 19,743,123 | 13.36 | $24.32 | $480,153,000 | SEC | ||
| 2018 Q1 | 19,743,123 | 10.58 | $17.09 | $337,410,000 | SEC | ||
| 2017 Q4 | 19,743,123 | 12.60 | Reduce 8.70% | 1.29 | $18.95 | $374,132,000 | SEC |
| 2017 Q3 | 21,623,886 | 14.85 | Buy | 14.85 | $17.60 | $380,580,000 | SEC |
| 2013 Q3 | 0 | 0.00 | Sell 100.00% | 6.09 | SEC | ||
| 2013 Q2 | 2,561,269 | 6.09 | $39.20 | $100,402,000 | SEC | ||
| 2013 Q1 | 2,561,269 | 10.54 | $39.68 | $101,631,000 | SEC | ||
| 2012 Q4 | 2,561,269 | 10.03 | Add 8.76% | 0.81 | $37.34 | $95,638,000 | SEC |
| 2012 Q3 | 2,355,000 | 12.18 | $41.41 | $97,521,000 | SEC | ||
| 2012 Q2 | 2,355,000 | 10.81 | $39.44 | $92,881,000 | SEC | ||
| 2012 Q1 | 2,355,000 | 10.68 | $45.06 | $106,116,000 | SEC | ||
| 2011 Q4 | 2,355,000 | 8.30 | Add 8.48% | 0.65 | $40.36 | $95,048,000 | SEC |
| 2011 Q3 | 2,171,000 | 8.56 | Buy | 8.56 | $37.22 | $80,805,000 | SEC |